September 21, 2023 – Page 9

Unrivaled Brands Settles Litigation Brought Against Insurer and Broker, Reaffirms Focus on Market Opportunities

Written by Customer Service on September 21, 2023. Posted in Public Companies.

SANTA ANA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) — Unrivaled Brands, Inc. (OTCQB: UNRV) (“Unrivaled,” “Unrivaled Brands,” or the “Company”), a cannabis company with operations throughout California, is pleased to announce the resolution of litigation with National Fire & Marine Insurance Company (“National Fire”) and Woodruff-Sawyer & Co. (“Woodruff-Sawyer”). Unrivaled alleged in the litigation that it had improperly been denied insurance coverage under a National Fire policy Unrivaled had obtained through its insurance broker, Woodruff-Sawyer. Robert Baca, Unrivaled’s Chief Legal Officer, noted, “This settlement follows closely on the heels of the settlement agreement reached with Mystic Holdings, Inc. Our history of resolving complex legal matters reflects our resilience and commitment to strategic thinking. While...

ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations

Written by Customer Service on September 21, 2023. Posted in Public Companies.

Company will leverage new capital inflow to optimize core business operations, advance strategic growth initiatives, and achieve cash flow breakeven PLEASANTON, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) — ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), today announced the completion of a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital, LLC. ProSomnus’s Executive Chair, Chief Executive Officer, and Chief Financial Officer are also participating in the financing. A description of the terms of the offering can be found in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 21, 2023. The new capital will be leveraged to optimize the Company’s...

Trident Enterprises Leaps Over Digital Hurdles with Bridgeline’s Advanced Search Solutions

Written by Customer Service on September 21, 2023. Posted in Public Companies.

WOBURN, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a leader in cloud-based marketing technology software, announced today that Trident Enterprises, a leading livestock fencing supplier, has selected Bridgeline’s powerful search solution to grow online revenue by enhancing their online search. This initiative will focus on two of Trident’s e-commerce sites: Easy Pet Fence Store and Deer Busters, accessible via www.easypetfence.com and www.deerbusters.com respectively. Trident selected HawkSearch for their site on BigCommerce grow eCommerce sales through search results that drive traffic and improve user experience. Customers will be able to quickly identify and buy products in Trident’s massive catalog with Bridgeline’s artificial intelligence powered search and natural language...

Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC

Written by Customer Service on September 21, 2023. Posted in Public Companies.

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation,” please visit: https://nnw.fm/619wq More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation of new treatments, particularly for rare diseases, is a key priority for the U.S. Food & Drug Administration. As part of that process, the agency can grant Orphan Drug Designation...

Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia

Written by Customer Service on September 21, 2023. Posted in Public Companies.

Intelligent Bio Solutions at the 2023 Workplace Health & Safety Show Intelligent Bio Solutions at the 2023 Workplace Health & Safety Show Intelligent Bio Solutions at the 2023 Workplace Health & Safety Show Intelligent Bio Solutions at the 2023 Workplace Health & Safety Show NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful debut of its Intelligent Fingerprinting Drug Screening System at the 2023 Workplace Health & Safety Show in Sydney, Australia on September 20th and 21st. The non-invasive, portable system is designed to enable workplace health and safety managers to conduct simple, non-invasive workplace...

SELLAS Announces Positive Topline Data in Lymphoma Cohort from SLS009 Phase 1 Dose-Escalation Trial, Supporting Advancement to Phase 2 Clinical Study; Primary and Secondary Endpoints Met

Written by Customer Service on September 21, 2023. Posted in Public Companies.

– 52 Relapsed and Refractory Lymphoma Patients Enrolled: 96% Alive at Last Assessment Indicating Favorable Survival Benefit – – Responses Observed Across Dose Levels with a 14.7% Clinical Response Rate Overall, 35.3% Overall Disease Control Rate, and 36.4% Clinical Response Rate in PTCL Patients – – Decrease in MCL1 and/or MYC Biomarkers Observed in 100% of Patients in a Dose-Dependent Manner in Once Per Week Administration Regimen – – Recommended Phase 2 Dose for Lymphoma Patients Established at 100 mg Once Per Week- – No Off-Target Safety Issues at any Dose Level – NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for...

GCANRx Featured in American Journal of Endocannabinoid Medicine

Written by Customer Service on September 21, 2023. Posted in Public Companies.

BALTIMORE, Sept. 21, 2023 (GLOBE NEWSWIRE) — Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that the Company and its scientific advisor, Dr. Adi Aran, has been featured in the American Journal of Endocannabinoid Medicine (AJEM). The feature, which can be found here, discusses the autism-cannabis connection and the mounting evidence of the therapeutic benefits of medical cannabis on neuropsychiatric disorders. The author, Larry Luxnor, quotes a number of medical specialists calling for evidence-based studies to direct the treatment of patients using cannabinoids. “There’s great basic science on the endocannabinoid system, but a lack of well-defined, evidence-based scientific studies,”...

Aircraft Aftermarket Parts Market to Reach USD 47.33 Billion by 2028, Supported by an In-Depth 200-Page Research Report

Written by Customer Service on September 21, 2023. Posted in Mergers And Acquisitions.

Aircraft Aftermarket Parts Market Aircraft Aftermarket Parts Market Pune, India, Sept. 21, 2023 (GLOBE NEWSWIRE) — The global aircraft aftermarket parts market size is expected to gain momentum by reaching USD 47.33 billion by 2028 while exhibiting a CAGR of 6.12% between 2023 and 2028. This information is published by Fortune Business Insights™ in its report, titled, “Aircraft Aftermarket Parts Market, 2023-2028.” The report further mentions that the market stood at USD 29.44 billion in 2020. Factors such as the increasing number of phasing out of the aging aircraft and the estimated growth in air travel in near future are expected to favor the product’s demand. For instance, according to Airbus SAS, the growth of passenger fleets will double from 21,000 aircraft in 2019 to 45,000 by 2035 due to the rising air...

BANXA Accelerates US Money Transmitter License Acquisitions, 32 Granted

Written by Customer Service on September 21, 2023. Posted in Public Companies.

TORONTO, Sept. 21, 2023 (GLOBE NEWSWIRE) — Banxa Holdings Inc. (TSXV: BNXA) (OTCQX: BNXAF) (FSE: AC00) (“Banxa” or the “Company“) today provides shareholders an update on its US operations, particularly its 32 Money Transmitter Licenses (MTLs) that have been granted to date. The US market is a very important part of Banxa’s growth strategy and where it continues to invest. Banxa is excited to announce the following: Banxa has now been granted Money Transmitter Licenses (MTLs) in the states of Tennessee, Virginia, Florida and Puerto Rico. With these latest additions, Banxa now holds 32 MTLs in the US, and is expecting 7 more MTLs to be granted in 2023 based on active applications. Banxa does not require MTLs to operate in 10 states / territories. Accordingly, Banxa is already capable of servicing 42 states...

Window Covering Market to Reach USD 19.02 Billion by 2030 | Featuring a Detailed 192-Page Research Report

Written by Customer Service on September 21, 2023. Posted in Mergers And Acquisitions.

Window Covering Market Window Covering Market Pune, India, Sept. 21, 2023 (GLOBE NEWSWIRE) — The global window covering market size was USD 13.04 billion in 2022 and is projected to grow from USD 13.68 billion in 2023 to USD 19.02 billion in 2030 at a CAGR of 4.82% during 2023-2030. The growing desire for eco-friendly products is anticipated to attract new entrants to the market. Advancements in the digital domain are projected to have a favorable impact on the global market during the entire forecast period. Fortune Business Insights presents this information in their report titled “Global Window Covering Market, 2023-2030.” Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/window-covering-market-104651 Leading Players Featured in the Research Report: Companies leading...

Day: September 21, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice